Elevance Health Inc. Stock Rises 1.9%, Outperforms Peers

Dow Jones2025-12-27

This article was automatically generated by Dow Jones using technology from Automated Insights.

Shares of Elevance Health Inc. advanced 1.9% to $349.88 on what proved to be an all-around mediocre trading session for the stock market, with the S&P 500 Index holding mostly steady at 6,929.94 and the Dow Jones Industrial Average remaining mostly unchanged at 48,710.97.

This was the stock's second consecutive day of gains.

Elevance Health Inc. closed 23.7% below its 52-week high of $458.75, which the company achieved on April 8th.

The stock outperformed some of its peers, as UnitedHealth Group Inc. rose 1.3% to $331.83, Cigna Group rose 0.6% to $276.51, and Humana Inc. rose 0.18% to $258.83.

Trading volume totaled 618,262, compared to the 50-day average of 1.7 million.

Data source: Dow Jones Market Data, FactSet

 

(END) Dow Jones Newswires

December 26, 2025 16:34 ET (21:34 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment